Pfizer-BioNTech Say Bivalent COVID-19 Booster Well Tolerated In Adults, Increases Neutralizing Antibodies Against BA.4 And BA.5 Variants

USA Today (10/13, Weintraub) reports Pfizer and BioNTech “announced Thursday that they now have data in adults one week after a 30-microgram booster that targets” Omicron subvariants BA.4 and BA.5. The article adds, “Two groups of 40 adults each, one age...